Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Cancer Communications

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3727/095535491820873146PMID 1653586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.

  1991cited by this paper
• Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: Increased PA activity correlates with biologically aggressive behavior

  1991cited by this paper
• Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display.

  1990cited by this paper
• An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells.

  1990cited by this paper
• Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.

  1990cited by this paper
• Insensitivity of laminin degradation directed by receptor bound urokinase to PAI-1 in cultured colon cancer.

  1990cited by this paper
• Urokinase receptors in lung cancer and normal lung.

  1990cited by this paper
• Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.

  1990cited by this paper
• Receptor‐mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI‐1.

  1990cited by this paper
• The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

  1990cited by this paper
• Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.

  1990cited by this paper
• Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells

  1989cited by this paper
• Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes.

  1989cited by this paper
• Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype.

  1989cited by this paper
• Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line.

  1989cited by this paper
• Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes.

  1989cited by this paper
• Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines.

  1988cited by this paper
• In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase

  1988cited by this paper
• Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.

  1988cited by this paper
• Tissue type plasminogen activator as a marker for functional zones, within the human prostate gland

  1988cited by this paper
• Binding of urokinase to specific receptor sites on human breast cancer membranes.

  1987cited by this paper
• Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas.

  1987cited by this paper
• A rapid in vitro assay for quantitating the invasive potential of tumor cells.

  1987cited by this paper
• The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type

  1986cited by this paper
• Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade.

  1986cited by this paper
• Measurement of Urokinase-Type Plasminogen Activator (u-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies

  1986cited by this paper
• Degradation of Glycoprotein and Collagenous Components of the Basement Membrane: Studies with Urokinase-Type Plasminogen Activator, α-Thrombin, and Plasmin

  1986cited by this paper
• Autocrine saturation of pro-urokinase receptors on human A431 cells.

  1986cited by this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cited by this paper
• Urokinase binding sites on human foreskin cells. Evidence for occupancy with endogenous urokinase.

  1985cited by this paper
• Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.

  1985cited by this paper
• A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

  1985cited by this paper
• Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.

  1985cited by this paper
• Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues.

  1984cited by this paper
• Tissue plasminogen activator activity in prostatic cancer.

  1984cited by this paper
• LNCaP model of human prostatic carcinoma.

  1983cited by this paper
• Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors.

  1983cited by this paper
• Antibodies to plasminogen activator inhibit human tumor metastasis.

  1983cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis

  1982cited by this paper
• Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

  1981cited by this paper
• "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

  1981cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper
• Isolation of a human prostate carcinoma cell line (DU 145)

  1978cited by this paper

• miR‐27 and miR‐124 target AR coregulators in prostate cancer: Bioinformatics and in vitro analysis

  2022cites this paper
• Chemical constituents from basidiomycete Basidioradulum radula culture medium and their cytotoxic effect on human prostate cancer DU-145 cells.

  2021cites this paper
• Parameters Estimation in Phase-Space Landscape Reconstruction of Cell Fate: A Systems Biology Approach.

  2018cites this paper
• Systems Biology

  2018cites this paper
• Hörergebnisse nach transtemporaler Resektion kleiner (T1/T2) Akustikusneurinome

  2017cites this paper
• Phase transitions in tumor growth: IV relationship between metabolic rate and fractal dimension of human tumor cells

  2017cites this paper
• The role of WAVE (WASP-family-verprolin homologousproteins) 1, 2 and 3 on cellular migration and invasion of colorectal cancer

  2016cites this paper
• SFMBT2 (Scm-like with four mbt domains 2) negatively regulates cell migration and invasion in prostate cancer cells

  2016cites this paper
• Distinct impact of targeted actin cytoskeleton reorganization on mechanical properties of normal and malignant cells.

  2015cites this paper
• Phase transitions in tumor growth: II prostate cancer cell lines

  2014influential citation
• The molecular and cellular impact of wave interactions on the aggressiveness of PC-3 cells

  2014cites this paper
• Extracellular proliferating cell nuclear antigen as a marker and therapeutic target for cancer stem cells

  2014cites this paper
• Effect of broccoli bioactives on prostate cancer cell invasion in vitro

  2014cites this paper
• DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells

  2014cites this paper
• Modeling Extracellular Matrix Reorganization in 3D Environments

  2013cites this paper
• The effect of the Wilms' tumor gene 1 (WT1) on E-cadherin regulation and migration of prostate cancer cells

  2012cites this paper
• Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer

  2012cites this paper
• Etablissement d'un nouveau modèle pérclinique de cancer de la prostate et identification de biomarqueurs de résistance au docetaxel

  2011cites this paper
• A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis.

  2011cites this paper
• Overexpression of MMP-9 Contributes to Invasiveness of Prostate Cancer Cell Line LNCaP

  2011cites this paper
• Quantitative Analysis of the Effect of Cancer Invasiveness and Collagen Concentration on 3D Matrix Remodeling

  2011cites this paper
• Bioanalytical Microfluidic Devices and Methods for Analysis of Cancer Gene Expression

  2011cites this paper
• Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.

  2011cites this paper
• Investigational Angiogenesis Inhibitors

  2010cites this paper
• Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis.

  2009cites this paper
• Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.

  2009cites this paper
• Structure-function studies of the functional and binding epitope of the human 37 kDa laminin receptor precursor protein.

  2008cites this paper
• Beyond prostate-specific antigen: alternate serum markers

  2008cites this paper
• ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.

  2008cites this paper
• Régulation de PPARγ et son implication dans le métabolisme et le cancer

  2008cites this paper
• 1 a , 25-Dihydroxyvitamin D ( Calcitriol ) Inhibits the Invasiveness of Human Prostate Cancer Cells 1

  2008cites this paper
• Secretion of Matrix Metalloproteinases and Their Inhibitors ( Tissue Inhibitor of Metalloproteinases ) by Human Prostate in Explant Cultures : Reduced Tissue Inhibitor of Metailoproteinase Secretion by Malignant Tissues 1

  2007cites this paper
• Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector

  2007cites this paper
• Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.

  2007cites this paper
• Restructuring dynamics of du 145 and LNCaP prostate cancer spheroids

  2007cites this paper
• Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.

  2007cites this paper
• Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.

  2007cites this paper
• PPAR regulates E-cadherin expression and inhibits growth and invasion of prostate cancer

  2006cites this paper
• Peroxisome Proliferator-Activated Receptor γ Regulates E-Cadherin Expression and Inhibits Growth and Invasion of Prostate Cancer

  2006cites this paper
• RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

  2006cites this paper
• Future innovations in treating advanced prostate cancer.

  2006cites this paper
• The metastatic cascade in prostate cancer.

  2006cites this paper
• Current status of anti-angiogenesis therapy for prostate cancer.

  2006cites this paper
• The invasive behaviour of prostatic cancer cells is suppressed by inhibitors of tyrosine kinase

  2006cites this paper
• Amplification and Overexpression of ERBB2, uPA, TRPS1, EIF3S3 and MYC Genes in Prostate Cancer

  2006cites this paper
• Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.

  2005cites this paper
• 1α,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases

  2005cites this paper
• Spinal cord compression in prostate cancer

  2005cites this paper
• Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model

  2005cites this paper
• RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo*

  2005cites this paper
• Angiogenesis and prostate cancer tumor growth

  2004cites this paper
• Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells

  2004cites this paper
• Profiling of Proteolytic Activities Secreted by Cancer Cells using Phage Display Substrate Technology

  2004cites this paper
• Direct Binding of Neutral Endopeptidase 24.11 to Ezrin/Radixin/Moesin (ERM) Proteins Competes with the Interaction of CD44 with ERM Proteins*

  2004cites this paper
• Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted alpha-therapy with 213Bi-conjugates.

  2004cites this paper
• Application of in‐gel protease assay in a biological sample: Characterization and identification of urokinase‐type plasminogen activator (uPA) in secreted proteins from a prostate cancer cell line PC‐3

  2004cites this paper
• Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines

  2004cites this paper
• Angiogenesis in Prostate Cancer: Biology and Therapeutic Opportunities

  2004cites this paper
• Cellular interactions in the tropism of prostate cancer to bone

  2004cites this paper
• Formation of Polyomavirus-Like Particles with Different VP1 Molecules That Bind the Urokinase Plasminogen Activator Receptor

  2003influential citation
• Immunohistochemical analysis of differentiation in static and mixed prostate cancer spheroids

  2003cites this paper
• Lycopene Increases Urokinase Receptor and Fails to Inhibit Growth or Connexin Expression in a Metastatically Passaged Prostate Cancer Cell Line: A Brief Communication

  2003cites this paper
• Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non‐antimicrobial tetracycline analog (COL‐3) in a metastatic prostate cancer model

  2002cites this paper
• Reduced plasma levels of coagulation factors in relation to prostate cancer

  2002cites this paper
• Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies

  2002cites this paper
• Induction of invasive phenotype by Casodex in hormone-sensitive prostate cancer cells.

  2002cites this paper
• Signal transduction-mediated regulation of urokinase gene expression in human prostate cancer.

  2001cites this paper
• Reactive stroma in prostate cancer progression.

  2001cites this paper
• Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells.

  2001cites this paper
• Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancer.

  2001cites this paper
• Forum: Brief Communication Variations of Components of the Plasminogen Activation System With the Cell Cycle in Benign Prostate Tissue and Prostate Cancer

  2001cites this paper
• Regulation of u‐PA gene expression in human prostate cancer

  2001cites this paper
• Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell line.

  2000cites this paper
• Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid‐mediated ovarian tumor cell migration

  2000cites this paper
• The role of receptors in prostate cancer.

  2000cites this paper
• Changes of the Coagulation and Fibrinolysis System in Malignancy: Their possible Impact on Future Diagnostic and Therapeutic Procedures

  2000cites this paper
• Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells.

  2000cites this paper
• The Urokinase Plasminogen Activation System in Breast Cancer

  1999cites this paper
• Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.

  1999cites this paper
• MMP Inhibition in Prostate Cancer

  1999cites this paper
• Regulation of Urokinase Production by Androgens in Human Prostate Cancer Cells: Effect on Tumor Growth and Metastases in Vivo1.

  1999cites this paper
• Regulation of urokinase production by androgens in human prostate cancer cells: effect on tumor growth and metastases in vivo.

  1999cites this paper
• Co-localization of urokinase and its receptor on established human umbilical vein endothelial cell.

  1999cites this paper
• Plasminogen activator system modulates invasivecapacity and proliferation in prostatic tumor cells

  1998cites this paper
• The effect of amiloride on the metastatic properties of prostate cancer in the Dunning rat model.

  1998cites this paper
• Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428.

  1998cites this paper
• Urokinase type plasminogen activator receptor expression in colorectal neoplasms

  1998cites this paper
• Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice.

  1998cites this paper
• Mechanism of invasion by prostate cancer

  1998cites this paper
• Potential Application of a Chemically Modified Non-Antimicrobial Tetracycline (CMT-3) Against Metastatic Prostate Cancer

  1998cites this paper
• In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor.

  1998cites this paper
• In vitro inhibition of human malignant brain tumour cell line proliferation by anti-urokinase-type plasminogen activator monoclonal antibodies.

  1998cites this paper
• Suppression of the growth and invasiveness of human prostate cancer cells in vitro by neuropeptide antagonist substance P analogues.

  1998cites this paper
• Analysis of fibrinolytic proteins in relation to DNA ploidy in prostate cancer

  1998cites this paper
• Breast cancer metastasis-associated genes: prognostic significance and therapeutic implications.

  1997cites this paper
• Metastasis induced by overexpression of p185neu‐T after orthotopic injection into a prostatic epithelial cell line (NbE)

  1997cites this paper
• Protease levels in breast, ovary, and other gynecological tumor tissues: prognostic importance in breast cancer.

  1997cites this paper
• Expression of urokinase‐type plasminogen activator receptor in hepatocellular carcinoma

  1997cites this paper
• Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines.

  1997cites this paper
• Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: Correlation with metastatic behavior in vivo

  1997cites this paper